Skip to main content

Articles

Page 1 of 77

  1. Studies have confirmed that epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC)-like properties are conducive to cancer metastasis. In recent years, testes-specific protease 50 (TSP50) has been ...

    Authors: Feng Gao, Sichen Liu, Jing Wang, Gang Wei, Chunlei Yu, Lihua Zheng, Luguo Sun, Guannan Wang, Ying Sun, Yongli Bao and Zhenbo Song
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:201
  2. The progression of non-small cell lung cancer (NSCLC) is significantly influenced by circular RNAs (circRNAs), especially in tumor hypoxia microenvironment. However, the precise functions and underlying mechan...

    Authors: Lixia Li, Dewei Liu, Tingting Chen, Chunhui Wei, Youping Qiao, Weiliang Liu, Yanmei Liang, Zhu Liang, Chunyuan Chen, Dongming Li, Bin Wu, Xuanna Zhao, Dan Huang and Dong Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:200
  3. Pancreatic cancer (PC) is a clinically challenging tumor to combat due to its advanced stage at diagnosis as well as its resistance to currently available therapies. The absence of early symptoms and known det...

    Authors: Carla Mottini, Francesca Romana Auciello, Isabella Manni, Christian Pilarsky, Damiano Caputo, Giulio Caracciolo, Alessandro Rossetta, Elena Di Gennaro, Alfredo Budillon, Giovanni Blandino, Maria Serena Roca and Giulia Piaggio
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:198
  4. Plasmacytoid dendritic cells (pDCs) are multifaceted immune cells executing various innate immunological functions. Their first line of defence consists in type I interferons (I-IFN) production upon nucleic ac...

    Authors: Matilde Monti, Giorgia Ferrari, Luisa Gazzurelli, Mattia Bugatti, Fabio Facchetti and William Vermi
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:196
  5. Metastasis is the major cause of colorectal cancer (CRC) mortality. Emerging evidence suggests that long noncoding RNAs (lncRNAs) drive cancer metastasis and that their regulatory pathways could be targeted fo...

    Authors: Yunze Liu, Heng Lv, Xin Liu, Lei Xu, Tiankang Li, Hui Zhou, Hongmei Zhu, Chuanchuan Hao, Changwei Lin and Yi Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:195
  6. Continued exploration of the androgen receptor (AR) is crucial, as it plays pivotal roles in diverse diseases such as prostate cancer (PCa), serving as a significant therapeutic focus. Therefore, the Departmen...

    Authors: Justus Simon Israel, Laura-Maria Marcelin, Christian Thomas, Eva Szczyrbová, Susanne Fuessel, Martin Puhr, Johannes Linxweiler, Shivani Yalala, Wilbert T. Zwart, Aria Baniahmad, Jasper van Goubergen, Harri M. Itkonen, Adam Sharp, Edward O’Neill, Marc Pretze, Matthias Miederer…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:194
  7. Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the expression of anti-phagocytic signals, most commonly CD47. In Ewing sarcoma (ES...

    Authors: Wen Luo, Hai Hoang, Katherine E. Miller, Hongwen Zhu, Serena Xu, Xiaokui Mo, Elizabeth A. R. Garfinkle, Heather Costello, Saranga Wijeratne, Wiebke Chemnitz, Ronan Gandhi, Yanling Liao, Janet Ayello, Aliza Gardenswartz, Jeremy M. Rosenblum, Kevin A. Cassady…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:193
  8. Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in overall survival but is associated with severe toxicities. Thus, to reduce...

    Authors: Prachi Bajpai, Sumit Agarwal, Farrukh Afaq, Sameer Al Diffalha, Darshan S. Chandrashekar, Hyung-Gyoon Kim, Abigail Shelton, C. Ryan Miller, Santosh K. Singh, Rajesh Singh, Sooryanarayana Varambally, Ganji Purnachandra Nagaraju, Ashish Manne, Ravi Paluri, Moh’d Khushman and Upender Manne
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:192
  9. The potential involvement of circular RNAs (circRNAs) and N6-methyladenosine (m6A) modification in the progression of Wilms tumor (WT) has not been fully elucidated. This study investigates the regulatory mechani...

    Authors: Guannan Shu, Zhang Zhao, Tianxin Zhao, Changmi Deng, Jiangquan Zhu, Yufeng Han, Minyu Chen, Jiajia Jing, Gaochen Bai, Dian Li, Feng Li, Jing He, Wen Fu and Guochang Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:191
  10. Pyroptosis is a cell death process characterized by cell swelling until membrane rupture and release of intracellular contents. As an effective tumor treatment strategy, inducing tumor cell pyroptosis has rece...

    Authors: Mengyuan Hu, Fengying Deng, Xinlei Song, Hongkun Zhao and Fei Yan
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:190
  11. Distinguishing benign from malignant pancreaticobiliary disease is challenging because of the absence of reliable biomarkers. Circulating extracellular vesicles (EVs) have emerged as functional mediators betwe...

    Authors: Daniel S.K. Liu, Jisce R. Puik, Bhavik Y. Patel, Morten T. Venø, Mahrou Vahabi, Mireia Mato Prado, Jason P. Webber, Eleanor Rees, Flora M. Upton, Kate Bennett, Catherine Blaker, Benoit Immordino, Annalisa Comandatore, Luca Morelli, Shivan Sivakumar, Rutger-Jan Swijnenburg…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:189
  12. The vast majority of lncRNAs have low expression abundance, which greatly limits their functional range and impact. As a high expression abundance lncRNA, FGD5-AS1’s non-ceRNA biological function in cancer is ...

    Authors: Shanshan Qin, Yue Liu, Xiangang Zhang, Pan Huang, Lingyun Xia, Weidong Leng and Dandan Li
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:188
  13. Recent studies have highlighted the significant role of the NF-κB signaling pathway in the initiation and progression of cancer. Furthermore, long noncoding RNAs (lncRNAs) have been identified as pivotal regul...

    Authors: Feng Xiao, Hong Zhu, Yaping Xiong, Yun Guo, Zhe Zhang, Jie Zeng, Yao Xiao, Bin Liao, Xuesong Shang, Siyi Zhao, Guowen Hu, Kai Huang and Hua Guo
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:187
  14. Authors: Fei Xiong, Da Wang, Wei Xiong, Xin Wang, Wen-hua Huang, Guan-hua Wu, Wen-zheng Liu, Qi Wang, Jun-sheng Chen, Yi-yang Kuai, Bing Wang and Yong-jun Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:186

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:152

  15. Metastasis is the leading cause of mortality in patients with colorectal cancer (CRC) and angiogenesis is a crucial factor in tumor invasion and metastasis. Long noncoding RNAs (lncRNAs) play regulatory functi...

    Authors: Lisha Chang, Jie Ding, Juan Pu, Jing Zhu, Xiang Zhou, Qian Luo, Jie Li, Mengsen Qian, Shuhui Lin, Juan Li and Keming Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:185
  16. Hodgkin lymphoma (HL) represents a neoplasm primarily affecting adolescents and young adults, necessitating the development of precise diagnostic and monitoring tools. Specifically, classical Hodgkin lymphoma ...

    Authors: Jesús Velasco-Suelto, Laura Gálvez-Carvajal, Iñaki Comino-Méndez and Antonio Rueda-Domínguez
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:184
  17. Leukocyte Ig-like receptor B family 4 (LILRB4) as an immune checkpoint on myeloid cells is a potential target for tumor therapy. Extensive osteolytic bone lesion is the most characteristic feature of multiple ...

    Authors: Hongying Wang, Lei Wang, Huiwen Luan, Jing Xiao, Zhiling Zhao, Pengfei Yu, Mi Deng, Yifan Liu, Shuhao Ji, Junjie Ma, Yan Zhou, Jiashen Zhang, Xianhui Meng, Juan Zhang, Xinyu Zhao, Chunling Li…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:183
  18. During targeted treatment, HER2-positive breast cancers invariably lose HER2 DNA amplification. In contrast, and interestingly, HER2 proteins may be either lost or gained. To longitudinally and systematically ...

    Authors: Elena Giordani, Matteo Allegretti, Alberto Sinibaldi, Francesco Michelotti, Gianluigi Ferretti, Elena Ricciardi, Giovanna Ziccheddu, Fabio Valenti, Simona Di Martino, Cristiana Ercolani, Diana Giannarelli, Grazia Arpino, Stefania Gori, Claudia Omarini, Alberto Zambelli, Emilio Bria…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:182
  19. This study aimed to develop a novel six-gene expression biomarker panel to enhance the early detection and risk stratification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer (L...

    Authors: Ping’an Ding, Haotian Wu, Jiaxiang Wu, Tongkun Li, Renjun Gu, Lilong Zhang, Peigang Yang, Honghai Guo, Yuan Tian, Jinchen He, Jiaxuan Yang, Ning Meng, Xiaolong Li, Lingjiao Meng and Qun Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:181
  20. Triple-negative breast cancer (TNBC) is characterized by its high metastatic potential, which results in poor patient survival. Cancer-associated fibroblasts (CAFs) are crucial in facilitating TNBC metastasis ...

    Authors: Shuangqin Fan, Xiaomin Yan, Xiaoxia Hu, Xing Liu, Shijie Zhao, Yue Zhang, Xiaofeng Zhou, Xiangchun Shen, Qi Qi and Yan Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:180
  21. Enhancer reprogramming plays a significant role in the heterogeneity of cancer. However, we have limited knowledge about the impact of chromatin remodeling in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP...

    Authors: Giacomo Corleone, Cristina Sorino, Matteo Caforio, Stefano Di Giovenale, Francesca De Nicola, Frauke Goeman, Valentina Bertaina, Angela Pitisci, Clelia Cortile, Franco Locatelli, Valentina Folgiero and Maurizio Fanciulli
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:179
  22. Authors: Jiaojiao Hao, Wenhua Fan, Yizhuo Li, Ranran Tang, Chunfang Tian, Qian Yang, Tianhua Zhu, Chaoliang Diao, Sheng Hu, Manyu Chen, Ping Guo, Qian Long, Changlin Zhang, Ge Qin, Wendan Yu, Miao Chen…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:178

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:48

  23. Paclitaxel (PTX) treatment resistance is an important factor leading to poor prognosis in triple-negative breast cancer (TNBC), therefore there is an urgent need to identify new target for combination therapy....

    Authors: Bowen Zheng, Fengyuan Qian, Xuehui Wang, Yuying Wang, Baian Zhou and Lin Fang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:177
  24. Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor outcomes, especially in older AML patients. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is considered a promising antica...

    Authors: Jun Ren, Junpeng Huang, Zailin Yang, Minghui Sun, Jing Yang, Can Lin, Fangfang Jin, Yongcan Liu, Lisha Tang, Jiayuan Hu, Xingyu Wei, Xinyi Chen, Zihao Yuan, Zesong Yang, Yanmeng Chen and Ling Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:176
  25. Authors: Rula Atwani, Rohit Pravin Nagare, Amber Rogers, Mayuri Prasad, Virginie Lazar, George Sandusky, Yan Tong, Fabrizio Pin and Salvatore Condello
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:175

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:156

  26. The androgen receptor (AR) is a drug target used to inhibit AR and prostate cancer (PCa) growth. Surprisingly, treatment with supraphysiological androgen level (SAL), used in bipolar androgen therapy, inhibits...

    Authors: Mehdi Heidari Horestani, Golnaz Atri Roozbahani and Aria Baniahmad
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:174
  27. Though tamoxifen achieves success in treating estrogen receptor α (ERα)-positive breast cancer, the followed development of tamoxifen resistance is a common challenge in clinic. Signals downstream of prolactin...

    Authors: Jiawei Zhang, Junjun Liu, Yali Yue, Lei Wang, Qunye He, Shuyi Xu, Junyan Li, Yunji Liao, Yu Chen, Shusheng Wang, Yueqing Xie, Baohong Zhang, Yanlin Bian, Dimiter S. Dimitrov, Yunsheng Yuan and Jianwei Zhu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:173
  28. The cyclin D1-cyclin dependent kinases (CDK)4/6 inhibitor palbociclib in combination with endocrine therapy shows remarkable efficacy in the management of estrogen receptor (ER)-positive and HER2-negative adva...

    Authors: Marianna Talia, Francesca Cirillo, Domenica Scordamaglia, Marika Di Dio, Azzurra Zicarelli, Salvatore De Rosis, Anna Maria Miglietta, Carlo Capalbo, Ernestina Marianna De Francesco, Antonino Belfiore, Fedora Grande, Bruno Rizzuti, Maria Antonietta Occhiuzzi, Giancarlo Fortino, Antonella Guzzo, Gianluigi Greco…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:171
  29. Recent intravesical administration of adenoviral vectors, either as a single injection or in combination with immune checkpoint inhibitors, exemplified by cretostimogene grenadenorepvec and nadofaragene firade...

    Authors: Dae Hoon Lee, Jung Ki Yoo, Ki Hwan Um, Wootae Ha, Soo Min Lee, Junseong Park, Min Jeong Kye, Jungyo Suh and Jin Woo Choi
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:170
  30. Cancer is characterized by dysregulated cellular metabolism. Thus, understanding the mechanisms underlying these metabolic alterations is important for developing targeted therapies. In this study, we investig...

    Authors: Jing-Xing Yang, Yu-Chen Chuang, Jen-Chih Tseng, Yi-Ling Liu, Chao-Yang Lai, Alan Yueh-Luen Lee, Chi-Ying F. Huang, Yi-Ren Hong and Tsung-Hsien Chuang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:169
  31. PANoptosis represents a novel type of programmed cell death (PCD) with distinctive features that incorporate elements of pyroptosis, apoptosis, and necroptosis. PANoptosis is governed by a newly discovered cyt...

    Authors: Lixia Gao, Chloe Shay and Yong Teng
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:168
  32. Authors: Nan Jing, Xinxing Du, Yu Liang, ZhenKeke Tao, Shijia Bao, Huixiang Xiao, Baijun Dong, Wei-Qiang Gao and Yu-Xiang Fang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:167

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:144

  33. Breast cancer (BC) is a complex disease, showing heterogeneity in the genetic background, molecular subtype, and treatment algorithm. Historically, treatment strategies have been directed towards cancer cells,...

    Authors: Vitale Del Vecchio, Ayesha Rehman, Sameer Kumar Panda, Martina Torsiello, Martina Marigliano, Maria Maddalena Nicoletti, Giuseppe Andrea Ferraro, Vincenzo De Falco, Rosamaria Lappano, Eva Lieto, Francesca Pagliuca, Carlo Caputo, Marcella La Noce, Gianpaolo Papaccio, Virginia Tirino, Nirmal Robinson…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:166
  34. Pancreatic ductal adenocarcinoma (PDAC) is the most lethal cancer with an aggressive metastatic phenotype and very poor clinical prognosis. Interestingly, a lower occurrence of PDAC has been described in indiv...

    Authors: Eduardo Ibello, Federica Saracino, Donatella Delle Cave, Silvia Buonaiuto, Filomena Amoroso, Gennaro Andolfi, Marco Corona, Ombretta Guardiola, Vincenza Colonna, Bruno Sainz Jr, Lucia Altucci, Dario De Cesare, Gilda Cobellis, Enza Lonardo, Eduardo Jorge Patriarca, Cristina D’Aniello…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:165
  35. Understanding the mechanisms that mediate the interaction between tumor and immune cells may provide therapeutic benefit to patients with cancer. The N6-methyladenosine (m6A) demethylase, ALKBH5 (alkB homolog ...

    Authors: Xin Hua, Qiuli Xu, Ranpu Wu, Wei Sun, Yanli Gu, Suhua Zhu, Xin Liu, Tangfeng Lv and Yong Song
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:164
  36. Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer subtype often treated with radiotherapy (RT). Due to its intrinsic heterogeneity and lack of effective targets, it is crucial t...

    Authors: Sushmitha Sriramulu, Shivani Thoidingjam, Wei-Min Chen, Oudai Hassan, Farzan Siddiqui, Stephen L. Brown, Benjamin Movsas, Michael D. Green, Anthony J. Davis, Corey Speers, Eleanor Walker and Shyam Nyati
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:163
  37. Authors: Luca Varinelli, Davide Battistessa, Marcello Guaglio, Susanna Zanutto, Oscar Illescas, Ewelina J. Lorenc, Federica Pisati, Shigeki Kusamura, Laura Cattaneo, Giovanna Sabella, Massimo Milione, Alessia Perbellini, Sara Noci, Cinzia Paolino, Elisabetta Kuhn, Margherita Galassi…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:162

    The original article was published in Journal of Experimental & Clinical Cancer Research 2024 43:132

  38. Cancer-associated fibroblasts (CAFs) play a significant role in fueling prostate cancer (PCa) progression by interacting with tumor cells. A previous gene expression analysis revealed that CAFs up-regulate gen...

    Authors: Valentina Doldi, Monica Tortoreto, Maurizio Colecchia, Massimo Maffezzini, Stefano Percio, Francesca Giammello, Federico Brandalise, Paolo Gandellini and Nadia Zaffaroni
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:161
  39. The tetraspanin family plays a pivotal role in the genesis of migrasomes, and Tetraspanin CD151 is also implicated in neovascularization within tumorous contexts. Nevertheless, research pertaining to the invol...

    Authors: Kangnan Zhang, Zhenhua Zhu, Rongrong Jia, NA Wang, Min Shi, Yugang Wang, Shihao Xiang, Qinghui Zhang and Ling Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:160
  40. Renal cell carcinoma (RCC) was historically considered to be less responsive to radiation therapy (RT) compared to other cancer indications. However, advancements in precision high-dose radiation delivery thro...

    Authors: Hari K. Rachamala, Vijay S. Madamsetty, Ramcharan S. Angom, Naga M. Nakka, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay and Krishnendu Pal
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:159
  41. Studies have shown that oxidative stress and its resistance plays important roles in the process of tumor metastasis, and mitochondrial dysfunction caused by mitochondrial DNA (mtDNA) damage is an important mo...

    Authors: Zhuan Zhou, Chunhui Qu, Peijun Zhou, Qin Zhou, Dan Li, Xia Wu and Lifang Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:158
  42. Phosphoinositide-3-kinase γ (PI3Kγ) plays a critical role in pancreatic ductal adenocarcinoma (PDA) by driving the recruitment of myeloid-derived suppressor cells (MDSC) into tumor tissues, leading to tumor gr...

    Authors: Claudia Curcio, Gianluca Mucciolo, Cecilia Roux, Silvia Brugiapaglia, Alessandro Scagliotti, Giorgia Guadagnin, Laura Conti, Dario Longo, Demis Grosso, Mauro Giulio Papotti, Emilio Hirsch, Paola Cappello, Judith A. Varner and Francesco Novelli
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:157
  43. Platinum-based chemotherapy regimens are a mainstay in the management of ovarian cancer (OC), but emergence of chemoresistance poses a significant clinical challenge. The persistence of ovarian cancer stem cel...

    Authors: Rula Atwani, Rohit Pravin Nagare, Amber Rogers, Mayuri Prasad, Virginie Lazar, George Sandusky, Yan Tong, Fabrizio Pin and Salvatore Condello
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:156

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2024 43:175

  44. Longitudinal sampling of tumor tissue from patients with solid cancers, aside from melanoma and a few other cases, is often unfeasible, and thus may not capture the plasticity of interactions between the tumor...

    Authors: Stephanie C. Pitts, Jeffrey Schlom and Renee N. Donahue
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:155
  45. RNA modifications of transfer RNAs (tRNAs) are critical for tRNA function. Growing evidence has revealed that tRNA modifications are related to various disease processes, including malignant tumors. However, t...

    Authors: Dan Du, Mingxia Zhou, Chenxi Ju, Jie Yin, Chang Wang, Xinyu Xu, Yunqing Yang, Yun Li, Le Cui, Zhengyang Wang, Yuqing Lei, Hongle Li, Fucheng He and Jing He
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:154
  46. Surgery represents the only curative treatment option for pancreatic ductal adenocarcinoma (PDAC), but recurrence in more than 85% of patients limits the success of curative-intent tumor resection. Neural inva...

    Authors: Andreas Göhrig, Georg Hilfenhaus, Friederike Rosseck, Martina Welzel, Benjamin Moser, Gianluca Barbone, Catarina Alisa Kunze, Johannes Rein, Gregor Wilken, Michael Böhmig, Thomas Malinka, Frank Tacke, Marcus Bahra, Katharina M. Detjen and Christian Fischer
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:153
  47. SMYD3 has been found implicated in cancer progression. Its overexpression correlates with cancer growth and invasion, especially in gastrointestinal tumors. SMYD3 transactivates multiple oncogenic mechanisms, ...

    Authors: Paola Sanese, Katia De Marco, Martina Lepore Signorile, Francesca La Rocca, Giovanna Forte, Marialaura Latrofa, Candida Fasano, Vittoria Disciglio, Elisabetta Di Nicola, Antonino Pantaleo, Giusy Bianco, Vito Spilotro, Claudia Ferroni, Matilde Tubertini, Nicoletta Labarile, Lucia De Marinis…
    Citation: Journal of Experimental & Clinical Cancer Research 2024 43:151

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 11.4
    5-year Journal Impact Factor: 11.4
    Source Normalized Impact per Paper (SNIP): 1.770
    SCImago Journal Rank (SJR): 2.806

    Speed 2023
    Submission to first editorial decision (median days): 5
    Submission to acceptance (median days): 100

    Usage 2023
    Downloads: 3,003,080
    Altmetric mentions: 3,022